BioSpace News Archive

Foghorn® Therapeutics Inc. (Foghorn), a company advancing an entirely new class of medicines targeting diseases with genetically determined dependencies in the chromatin regulatory system, today appointed Scott Biller, Ph.D., to its Board of Directors.

Biotechnology plays an important role throughout various sectors by improving industry standards, services, and developing new products.

The company will present as Immunis.AI at the 2020 Biotech Showcase, being held January 13-15, 2020 in San Francisco, California.

Prime Therapeutics LLC, a pharmacy benefit manager serving more than 28 million members nationally, has welcomed David Schlett as its new chief financial officer.

Cancer immunotherapy leader joins Immuneering’s executive team to apply the company’s Disease Cancelling Technology to immuno-oncology

InnerScope, the creator of a Point of Sale Hearing Screening Retail Kiosk has developed a new fully automated Retail Shelf-Top design of its Point of Sale Hearing Screening Kiosk for major “Big Box” retailers and pharmacy chains

Molecular genetics company MiraDx today announced it is opening patient enrollment in collaboration with UCLA for a first-ever non-tumor based microRNA biomarker-driven clinical trial for KRAS-variant positive HPV-positive head and neck cancer patients (HNSCC).

Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), has signed a $150 million USD international marketing partnership agreement with Regenerative Medicine of China, Inc. for the exclusive rights to market and sell all biological drugs developed by Zhittya during a 30-year time period.

An $8 million gift from the Foundation of Caring will help CHOC Children’s advance research for a rare lysosomal storage disease, ultimately leading to an improved understanding and more effective treatments.

Proprio, the Seattle firm enabling surgeons to perform complex procedures, utilizing proprietary imaging techniques and mixed reality environments for more precise surgical navigation, has appointed Dr. Takeo Kanade to its Advisory Board.